Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis

被引:49
作者
Furrer, H [1 ]
Opravil, M
Bernasconi, E
Telenti, A
Egger, M
机构
[1] Univ Bern, Div Infect Dis, CH-3010 Bern, Switzerland
[2] Univ Zurich, Div Infect Dis, Zurich, Switzerland
[3] Cantonal Hosp Lugano, Div Internal Med, Lugano, Switzerland
[4] Univ Lausanne, Div Infect Dis, Lausanne, Switzerland
[5] Univ Bristol, Dept Social Med, Div Infect Dis, MRC,Hlth Serv Res Collaborat, Bristol, Avon, England
关键词
D O I
10.1016/S0140-6736(00)02407-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Discontinuation of primary prophylaxis against toxoplasma encephalitis was studied in 199 HIV-1-infected patients on antiretroviral combination treatment who had experienced a sustained increase in their CD4 count. During a follow-up of 272 person-years, no cases of toxoplasma encephalitis arose.
引用
收藏
页码:2217 / 2218
页数:2
相关论文
共 5 条
[1]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[2]   LOW-DOSE TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS [J].
CARR, A ;
TINDALL, B ;
BREW, BJ ;
MARRIOTT, DJ ;
HARKNESS, JL ;
PENNY, R ;
COOPER, DA .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) :106-111
[3]   Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].
Egger, M ;
Hirschel, B ;
Francioli, P ;
Sudre, P ;
Wirz, M ;
Flepp, M ;
Rickenbach, M ;
Malinverni, R ;
Vernazza, P ;
Battegay, M ;
Bernasconi, E ;
Burgisser, P ;
Erb, P ;
Fierz, W ;
Grob, P ;
Gruninger, U ;
Jeannerod, L ;
Ledergerber, B ;
Luthy, R ;
Matter, L ;
Opravil, M ;
Paccaud, F ;
Perrin, L ;
Pichler, W ;
Piffaretti, GC ;
Rutschmann, O ;
Zanetti, G .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199
[4]   Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy [J].
Furrer, H ;
Egger, M ;
Opravil, M ;
Bernasconi, E ;
Hirschel, B ;
Battegay, M ;
Telenti, A ;
Vernazza, PL ;
Rickenbach, M ;
Flepp, M ;
Malinverni, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (17) :1301-1306
[5]   ONCE-WEEKLY ADMINISTRATION OF DAPSONE PYRIMETHAMINE VS AEROSOLIZED PENTAMIDINE AS COMBINED PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA AND TOXOPLASMIC ENCEPHALITIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS [J].
OPRAVIL, M ;
HIRSCHEL, B ;
LAZZARIN, A ;
HEALD, A ;
PECHERE, M ;
RUTTIMANN, S ;
ITEN, A ;
VONOVERBECK, J ;
OERTLE, D ;
PRAZ, G ;
VUITTON, A ;
MAININI, F ;
LUTHY, R .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) :531-541